"Strategico avere sperimentazioni cliniche e pre-cliniche in Italia per impatto rilevante sulla vita di tutti noi. Alla base dello sviluppo di una nuova #terapia ci sono le #imprese, grandi ma anche medio-piccole". Il nostro consigliere @pigiparacchi live: https://t.co/ph2PheBvcF
Nucleate welcomes this conversation on connecting international biotech investors and founders in Italy.
We thank our Nucleate Italy and @pigiparacchi for organizing.
https://t.co/m4ORPzjK3j
Da un'idea alla quotazione in borsa: quella di @GenentaScience è la storia di un vero caso di successo. Al #SIOS23 Summer ci sarà @pigiparacchi, CEO e co-founder di Genenta Science (Nasdaq: $GNTA)
Registrati👉 https://t.co/yjetbuLMwG
Main partner @SACEgroup in collab. @UniLUISS
Join the the first fireside chat #InnovitforLifeSciences that brings together the competitiveness of 🇮🇹 Life Sciences 🩺and the experience of 🇺🇸 Investors 🎆
Registration: https://t.co/EKM7AMTcTG
@GenentaScience@NIH
Join us for a live session that brings together the competitiveness of Italian Life Sciences and the experience of US Investors.
Innovit for Life Sciences > Road to #JPM24
On Tuesday 27th June 2023 10.30am EDT - 4.30pm CET
@GenentaScience@AssobiotecF
See these #healthcare management teams present live and submit your questions during their Q&A. $ACU $CYTO $ANPC $BXRX $CRDL $COYA $HUGE $GNTA $GNPX $HILS $HUMA $INFU $IKT $KTRA
https://t.co/8UFQIbFT0m
All investors are welcome to join free of charge:
https://t.co/aqwSZlRHcR
Our lead candidate is a lenti-virus based hematopoietic stem progenitor cell #immunotherapy enabling controlled and targeted interferon-α expression within #cancers. Learn more: https://t.co/wNvMLbRm9A
At Genenta, our scientists bring a unique blend of multi-disciplinary competence, vast experience in #CellTherapy, and a commensurate track-record in the forefront of therapies and #DrugDevelopment. Learn more: https://t.co/Gd3fo4cKsx